ABOUT
    ABOUT US
    LEADERSHIP
        Executive Team
    MILESTONE
PRODUCT
    ALL
    Iron Deficiency Anemia
    Emergency Care
    Respiratory
PIPELINE
    PIPELINE
        Respiratory
        Pain Management
        Emergency Care
        Iron Deficiency Anemia
PARTNERSHIP
NEWS
    ALL
    Press Releases
        优锐医药完成数亿元对中健药业 100%股权的收购
        Strategic Cooperation Agreement with SHAPHAR
        【优锐伙伴】Bentrio™ 鼻喷剂 已获批美国FDA 510(k)许可
        【优锐伙伴】MVA-BN®RSV疫苗 荣获欧盟药品管理局 PRIME药物计划资格
        Nuance Pharma advances Rare Disease R&D with CORD
        NTM-001 Phase I Clinical Study Dosing Completion in HK
        【优锐伙伴】潜在“First in Class” 新药 Ensifentrine 全球III期临床试验成功
        COPD新药 Ensifentrine 全球III期临床 ENHANCE-2 试验全解读
        Nuance Pharma announces Ensifentrine China IND Approval
        优锐医药助力2022第十一届中国罕见病高峰论坛成功举办
        专访优锐医药:呼吸精品特药领域,如何打造现金“造血”教科书?
        优锐医药首席运营官陈晨 对话蔻德 - 新浪《蕊智会》
    Media
        Nuance Pharma Closes Series D Financing
        Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China
        Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
        Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines
        Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets
        Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets
        Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre
        Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China
        Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China
        Nuance Pharma announces partnership with DKSH to launch Bentrio™ Nasal Spray in Hong Kong and Macau
        Nuance Pharma announces partnership with DKSH to launch Bentrio™ Nasal Spray in Hong Kong and Macau
        专访优锐医药:呼吸精品特药领域,如何打造现金“造血”教科书?
        Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China
        Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China
    Partner News
        Verona Pharma Completes Enrollment in Phase 3 ENHANCE-1 Trial Evaluating Ensifentrine for Maintenance Treatment of COPD
        Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD
        Neumentum and Nuance Biotech Enter into Licensing Agreement for NTM-001 (ketorolac for IV infusion) in China
        Altamira Therapeutics Receives FDA 510(k) Clearance for Bentrio to Treat Allergic Rhinitis
        Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
        BAVARIAN NORDIC ANNOUNCES GRANT OF PRIME ELIGIBILITY FROM THE EUROPEAN MEDICINES AGENCY FOR ITS RSV VACCINE CANDIDATE FOR THE PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS IN OLDER ADULTS
        Verona Pharma Announces Analyses Demonstrating Ensifentrine Reduced Exacerbation Rates Across Subgroups in Phase 3 ENHANCE-2 Trial for COPD
        Nuance Pharma receives Clearance to begin Pivotal Clinical Trials with Ensifentrine for COPD in China
INVESTOR
CAREER
    PROFILE
CONTACT